Related Experiment Video
Updated: Aug 15, 2026

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection
Published on: September 2, 2014
Up-regulated expression of genes encoding Hrk and IL-3R beta subunit by TCDD in vivo and in vitro
1Department of Biology, Changwon National University, #9 Sarim-dong, Changwon, Kyungnam 641-773, South Korea. parkjh@sarim.changwon.ac.kr
Abstract:
Although 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) has been known for its immunosuppressive activity, the mechanisms of its action have been difficult to elucidate, partly because of its inability of exerting its effects in vitro. To gain insights into the molecular mechanisms of immunosuppressive effects of TCDD, we screened for genes, which are regulated by in vivo TCDD treatment in an allogeneic mouse tumor model. RNA, collected from lymphoid organs, was reverse-transcribed to cDNA and hybridized to DNA arrays. In addition to genes such as NF-kappa B p65 and p27(Kip1) which were previously shown to be regulated by TCDD, expression of several genes including Hrk and IL-3R beta (AIC-2A) was shown to be modulated. RT-PCR and Western blot analyses confirmed the differential expression of Hrk and IL-3R beta. Finally, Hrk was up-regulated by TCDD in Jurkat T cells, suggesting the potential role of Hrk in thymic atrophy and the possibility of exploiting Jurkat T cells as a suitable in vitro model for studying mechanisms of thymic atrophy.
Insights
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) causes immunosuppression by regulating genes like Hrk and IL-3R beta. This study identifies potential molecular mechanisms and an in vitro model for thymic atrophy.
Area of Science:
- Toxicology
- Immunology
- Molecular Biology
Background:
- 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is known for immunosuppressive effects.
- The precise molecular mechanisms underlying TCDD's immunosuppression are not fully understood, partly due to its limited in vitro activity.
Purpose of the Study:
- To investigate the molecular mechanisms of TCDD-induced immunosuppression.
- To identify genes regulated by TCDD in vivo using a mouse tumor model.
Main Methods:
- Gene expression profiling using DNA arrays on RNA from lymphoid organs of TCDD-treated mice.
- Reverse transcription PCR (RT-PCR) and Western blot analyses to confirm gene expression changes.
- In vitro experiments using Jurkat T cells to study TCDD effects on specific genes.
Main Results:
- TCDD treatment modulated the expression of several genes, including Hrk and IL-3R beta (AIC-2A), in addition to previously identified genes like NF-kappa B p65 and p27(Kip1).
- Differential expression of Hrk and IL-3R beta was confirmed by RT-PCR and Western blot.
- Hrk expression was upregulated by TCDD in Jurkat T cells.
Conclusions:
- Hrk may play a role in TCDD-induced thymic atrophy.
- Jurkat T cells show potential as an in vitro model for studying the mechanisms of thymic atrophy caused by TCDD.
Related Concept Videos
TGF - β Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

